ATE290370T1 - Zubereitungen mit lisinopril und ungemahlenem dcpd - Google Patents

Zubereitungen mit lisinopril und ungemahlenem dcpd

Info

Publication number: ATE290370T1
Authority: AT; Austria
Prior art keywords: lisinopril; dcpd; unground; preparations; composition
Prior art date: 2001-09-24

Application number

AT02758654T

Other languages

English (en)

Inventor

Ronald John Roberts

David Brandon Bowen

Original Assignee

Astrazeneca Uk Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-09-24

Filing date

2002-09-20

Publication date

2005-03-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25505851&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE290370(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2002-09-20 Application filed by Astrazeneca Uk Ltd filed Critical Astrazeneca Uk Ltd

2005-03-15 Application granted granted Critical

2005-03-15 Publication of ATE290370T1 publication Critical patent/ATE290370T1/de

Links

108010007859 Lisinopril Proteins 0.000 title abstract 6
229960002394 lisinopril Drugs 0.000 title abstract 6
RLAWWYSOJDYHDC-BZSNNMDCSA-N lisinopril Chemical compound C([C@H](N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(O)=O)C(O)=O)CC1=CC=CC=C1 RLAWWYSOJDYHDC-BZSNNMDCSA-N 0.000 title abstract 3
HECLRDQVFMWTQS-UHFFFAOYSA-N Dicyclopentadiene Chemical compound C1C2C3CC=CC3C1C=C2 HECLRDQVFMWTQS-UHFFFAOYSA-N 0.000 title 1
238000002360 preparation method Methods 0.000 title 1
XAAHAAMILDNBPS-UHFFFAOYSA-L calcium hydrogenphosphate dihydrate Chemical compound O.O.[Ca+2].OP([O-])([O-])=O XAAHAAMILDNBPS-UHFFFAOYSA-L 0.000 abstract 5
CZRQXSDBMCMPNJ-ZUIPZQNBSA-N lisinopril dihydrate Chemical compound O.O.C([C@H](N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(O)=O)C(O)=O)CC1=CC=CC=C1 CZRQXSDBMCMPNJ-ZUIPZQNBSA-N 0.000 abstract 3
239000000203 mixture Substances 0.000 abstract 2
239000007857 degradation product Substances 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
238000009472 formulation Methods 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
239000002245 particle Substances 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/556—Angiotensin converting enzyme inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Cardiology (AREA)
Inorganic Chemistry (AREA)
Vascular Medicine (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Heart & Thoracic Surgery (AREA)
Neurology (AREA)
Urology & Nephrology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Hospice & Palliative Care (AREA)
Anesthesiology (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Peptides Or Proteins (AREA)

AT02758654T 2001-09-24 2002-09-20 Zubereitungen mit lisinopril und ungemahlenem dcpd ATE290370T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US09/962,429 US6462022B1 (en)	2001-09-24	2001-09-24	Lisinopril compositions having large-particle DCPD
PCT/GB2002/004292 WO2003026622A1 (en)	2001-09-24	2002-09-20	Lisinopril compositions having large-particle dcpd

Publications (1)

Publication Number	Publication Date
ATE290370T1 true ATE290370T1 (de)	2005-03-15

Family

ID=25505851

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT02758654T ATE290370T1 (de)	2001-09-24	2002-09-20	Zubereitungen mit lisinopril und ungemahlenem dcpd

Country Status (10)

Country	Link
US (1)	US6462022B1 (de)
EP (1)	EP1432407B2 (de)
JP (1)	JP4084749B2 (de)
AT (1)	ATE290370T1 (de)
DE (1)	DE60203192T3 (de)
DK (1)	DK1432407T3 (de)
ES (1)	ES2236561T5 (de)
GB (1)	GB2384429B (de)
PT (1)	PT1432407E (de)
WO (1)	WO2003026622A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20070196477A1 (en) *	2004-04-30	2007-08-23	Withiam Michael C	Rapidly dissolving tablets comprising low surface area calcium phosphates
JP4925835B2 (ja)	2007-01-12	2012-05-09	日東電工株式会社	物質検知センサ
US20180325813A1 (en)	2015-11-07	2018-11-15	Ftf Pharma Private Limited	Oral solution of ace inhibitors
GB2595203A (en)	2020-03-03	2021-11-24	Alkaloid Ad Skopje	Formulation
CN119746022A (zh) *	2024-12-27	2025-04-04	江苏天士力帝益药业有限公司	一种赖诺普利氢氯噻嗪药物组合物及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4517179A (en) *	1983-04-29	1985-05-14	Pennwalt Corporation	Rapid dissolving, uniform drug compositions and their preparation
US4707361A (en) *	1985-08-02	1987-11-17	Stauffer Chemical Company	Granular anhydrous dicalcium phosphate compositions suitable for direct compression tableting
US4675188A (en) *	1985-08-02	1987-06-23	Stauffer Chemical Company	Granular anhydrous dicalcium phosphate compositions suitable for direct compression tableting
HU222489B1 (hu) †	1990-07-25	2003-07-28	Novartis Ag.	Stabilizált gyógyszerkészítmények és eljárás az előállításukra
CA2285430C (en) *	1997-04-01	2008-11-18	Cap Biotechnology, Inc.	Calcium phosphate microcarriers and microspheres
US6117451A (en) *	1998-08-25	2000-09-12	Pharmalogix, Inc.	Direct compression metformin hydrochloride tablets

2001
- 2001-09-24 US US09/962,429 patent/US6462022B1/en not_active Expired - Lifetime
2002
- 2002-09-20 AT AT02758654T patent/ATE290370T1/de active
- 2002-09-20 GB GB0311750A patent/GB2384429B/en not_active Expired - Fee Related
- 2002-09-20 ES ES02758654T patent/ES2236561T5/es not_active Expired - Lifetime
- 2002-09-20 EP EP02758654A patent/EP1432407B2/de not_active Expired - Lifetime
- 2002-09-20 DK DK02758654T patent/DK1432407T3/da active
- 2002-09-20 WO PCT/GB2002/004292 patent/WO2003026622A1/en not_active Ceased
- 2002-09-20 JP JP2003530259A patent/JP4084749B2/ja not_active Expired - Fee Related
- 2002-09-20 DE DE60203192T patent/DE60203192T3/de not_active Expired - Lifetime
- 2002-09-20 PT PT02758654T patent/PT1432407E/pt unknown

Also Published As

Publication number	Publication date
DE60203192T2 (de)	2006-04-13
GB2384429B (en)	2004-04-14
DE60203192D1 (de)	2005-04-14
DK1432407T3 (da)	2005-05-23
JP2005504803A (ja)	2005-02-17
DE60203192T3 (de)	2012-12-27
ES2236561T5 (es)	2012-10-30
EP1432407A1 (de)	2004-06-30
US6462022B1 (en)	2002-10-08
PT1432407E (pt)	2005-05-31
GB2384429A (en)	2003-07-30
EP1432407B2 (de)	2012-08-01
JP4084749B2 (ja)	2008-04-30
ES2236561T3 (es)	2005-07-16
WO2003026622A1 (en)	2003-04-03
GB0311750D0 (en)	2003-06-25
EP1432407B1 (de)	2005-03-09

Similar Documents

Publication	Publication Date	Title
LV12715A (lv)	2001-09-20	Dry mix formulation for bisphosphonic acids
BR0116832A (pt)	2004-02-03	Produto desodorante, método cosmético e método de fabricação de composição desodorante
MY118371A (en)	2004-10-30	Tetrahydrolipstatin containing compositions
CY1118211T1 (el)	2017-06-28	Φαρμακευτικες συνθεσεις που περιλαμβανουν ενωσεις λανθανιου
BRPI0108435B8 (pt)	2021-05-25	formulação e uso de entecavir de baixa dose
HUP9802287A2 (hu)	1999-02-01	Cinkkel és kívánt esetben lizinnel vagy kalciumionnal előkezelt növekedési hormont tartalmazó stabilizált gyógyszerkészítmény
TWI264311B (en)	2006-10-21	Method for manufacturing a low dose pharmaceutical composition having uniform drug distribution and potency
ZA917371B (en)	1992-06-24	Calcium uptake inhibitors
ES2160622T3 (es)	2001-11-16	Composicion a base de biopolimeros de hidratacion rapida.
ES2174054T3 (es)	2002-11-01	Composiciones farmaceuticas acuosas liquidas que comprenden alginato sodico y bicarbonato potasico.
DE60203192D1 (de)	2005-04-14	Zubereitungen mit lisinopril und ungemahlenem dcpd
MD2722B2 (ro)	2005-03-31	Compoziţie farmaceutică cu carbonat de calciu sau amestecul lui cu hidroxicarbonat de magneziu sau cu vitamina D, utilizată pentru profilaxia sau tratamentul osteoporozei
DE60309472D1 (de)	2006-12-14	Pharmazeutische formulierung mit einem nichtpeptidischen renin-hemmer und surfactant
ES2174734A1 (es)	2002-11-01	Nueva formulacion galenica de paracetamol dispersable y soluble, procedimiento para su preparacion y aplicaciones.
ATE44467T1 (de)	1989-07-15	Fibrinolytisches mittel und diffusionsfaktor enthaltende pharmazeutische zusammensetzung verwendbar zur behandlung des myokardinfarktes.
AU3004192A (en)	1993-06-17	Stabilized pharmaceutical composition of non-glycosylated recombinant human IL2 in reduced form and its preparation process
WO2004028457A3 (en)	2005-08-11	PHARMACEUTICAL COMPOSITION FOR IMPROVED ADMINISTRATION OF HIV gp41-DERIVED PEPTIDES, AND ITS USE IN THERAPY
HUP0004461A2 (hu)	2001-10-28	Apoliprotein B kiválasztást/mikroszomális trigliceridtranszfer-proteint gátló anyag alkalmazása gyógyászati készítmények előállítására és a fenti gyógyászati készítmények
AU8452791A (en)	1992-03-26	1-phenyl-3-aryl-2-propyne-1-ones
CA2122478A1 (en)	1993-05-27	Unit Dose Form of Bismuth Subsalicylate
DE60201022D1 (de)	2004-09-23	Antibiotische pharmazeutische formulierung mit lysergol zur verstärkung der wirksamkeit und behandlungsmethode
WO2003049668A3 (en)	2004-06-17	Method of administering calcium citrate
CO4290373A1 (es)	1996-04-17	PROCESOS PARA LA MANUFACTURA DE GRANULOS DETERGENTES QUE FLUYEN LIBREMENTE, CON UNA DENSIDAD AL GRANEL DE POR LO MENOS 600 g/l QUE COMPRENDEN ETAPAS DE NEUTRALIZACION DE ACIDOS, MEZCLA CON POLVOS Y SECADO OPCIONAL
KR20000061968A (ko)	2000-10-25	향기 치료요법에 쓰는 약용식물을 이용한 기능성 가구용품
AU5662996A (en)	1996-10-16	Compounds and compositions for delivering active agents

Legal Events

Date

Code

Title

Description

2005-10-15

UEP

Publication of translation of european patent specification

Ref document number: 1432407

Country of ref document: EP